Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

COVID-19

Recruiting

Investigational

A study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:MOLNUPIRAVIR

Contact Research Centre

COVID-19

Recruiting

Registered drugNo placebo

Study of Remdesivir to Prevent Severe COVID-19 in Kidney Transplant Recipients with No or Mild Symptoms

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Remdesivir

Contact Research Centre

COVID-19

Recruiting

Investigational

Study of ibuzatrelvir alone or combined with remdesivir in adults with COVID-19 who have severely compromised immune systems

Investigational

Belgium

Participants:18–64 years · 65+ years
Substances:IBUZATRELVIR

Contact Research Centre

COVID-19

Recruiting

Registered drugNo placebo

Study comparing intranasal COVID-19 vaccine (LVT-001) with mRNA vaccine (bretovameran) as booster doses in healthy adults

Registered drugNo placebo

France

Participants:18–64 years · Healthy volunteers
Substances:LVT-001

Contact Research Centre

COVID-19

Recruiting

Investigational

Study of ibuzatrelvir tablets in non-hospitalized adults and adolescents with COVID-19 who are at high risk of developing severe illness

Investigational

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:IBUZATRELVIR

Contact Research Centre

COVID-19+1

Not yet recruiting

Registered drugNo placebo

Effectiveness of mCOMBRIAX vaccine compared with high‑dose influenza vaccine and mRNA‑1273 in adults ≥65 years for prevention of influenza and COVID‑19

Registered drugNo placebo

Denmark

Participants:65+ years · Healthy volunteers
Substances:B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type)

Contact Research Centre

COVID-19

Not yet recruiting

Registered drugNo placebo

Study of nirmatrelvir and remdesivir to achieve viral clearance in immunocompromised patients with persistent COVID-19

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Nirmatrelvir

Contact Research Centre

COVID-19

Not yet recruiting

Registered drugNo placebo

Study of Intravenous Immunoglobulin Added to Standard Treatment for COVID-19 in Patients with Severely Weakened Immune System Due to B-cell Problems

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Nirmatrelvir

Contact Research Centre

COVID-19

Not yet recruiting

Registered drugNo placebo

Study on COVID-19 Immunity in Immunocompromised Adults Using Raxtozinameran and Bretovameran in Belgium

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Raxtozinameran

Contact Research Centre

COVID-19

Not yet recruiting

Registered drugNo placebo

Study on Metformin and Colchicine for Treating Long COVID Symptoms in Patients

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Colchicine

Contact Research Centre

COVID-19

Not yet recruiting

Registered drugNo placebo

Study on Post-Acute COVID-19 Syndrome: Effects of Diet, Exercise, Metformin, and Sirolimus on Frailty and Immune Function in Affected Patients

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Metformin

Contact Research Centre

COVID-19+3

Not yet recruiting

Registered drugNo placebo

Study on the Safety of Mercaptamine with Standard Therapy for Hospitalized COVID-19 Pneumonia Patients Not Requiring High Oxygen Flows

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Mercaptamine

Contact Research Centre

Find therapies in clinical trials near you

39 trials match your criteria

COVID-19

A study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness

COVID-19

Study of Remdesivir to Prevent Severe COVID-19 in Kidney Transplant Recipients with No or Mild Symptoms

COVID-19

Study of ibuzatrelvir alone or combined with remdesivir in adults with COVID-19 who have severely compromised immune systems

COVID-19

Study comparing intranasal COVID-19 vaccine (LVT-001) with mRNA vaccine (bretovameran) as booster doses in healthy adults

COVID-19

Study of ibuzatrelvir tablets in non-hospitalized adults and adolescents with COVID-19 who are at high risk of developing severe illness

COVID-19+1

Effectiveness of mCOMBRIAX vaccine compared with high‑dose influenza vaccine and mRNA‑1273 in adults ≥65 years for prevention of influenza and COVID‑19

COVID-19

Study of nirmatrelvir and remdesivir to achieve viral clearance in immunocompromised patients with persistent COVID-19

COVID-19

Study of Intravenous Immunoglobulin Added to Standard Treatment for COVID-19 in Patients with Severely Weakened Immune System Due to B-cell Problems

COVID-19

Study on COVID-19 Immunity in Immunocompromised Adults Using Raxtozinameran and Bretovameran in Belgium

COVID-19

Study on Metformin and Colchicine for Treating Long COVID Symptoms in Patients

COVID-19

Study on Post-Acute COVID-19 Syndrome: Effects of Diet, Exercise, Metformin, and Sirolimus on Frailty and Immune Function in Affected Patients

COVID-19+3

Study on the Safety of Mercaptamine with Standard Therapy for Hospitalized COVID-19 Pneumonia Patients Not Requiring High Oxygen Flows

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.